# Elevance Health

Type: Company (ELV)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/elevance-health
Canonical HTML page: https://gethealthbrief.com/entity/elevance-health

## Timeline

- **2026-02-23**: Payouts Begin — Distribution of funds to eligible individual and group policyholders officially starts.
- **2024**: Appeals & Processing — Legal appeals are resolved and the claims administrator processes millions of submissions.
- **2022-08-09**: Final Court Approval — U.S. District Court grants final approval to the settlement terms despite some objections.
- **2020-10-30**: Preliminary Settlement — BCBS Association agrees to a $2.67 billion settlement and structural changes.
- **2012-07-01**: Initial Lawsuit Filed — Policyholders file class-action suit alleging antitrust violations and geographic market division.

## Recent coverage (2 stories)

### Prior Auth Denials Hit 12–18% Across Public Plans; 67% Overturned in MA
2026-08-14 17:41:13 · Sentiment: Negative · Impact: 6/10 · Sources: 2

KFF's first analysis of mandatory 2026 prior authorization reporting reveals wide variation in denial rates across Medicare Advantage, Medicaid, and ACA Marketplace plans, with 12%-18% of standard requests denied and most appealed denials overturned. For healthcare leaders, the data expose care access barriers and administrative friction that vary sharply by insurer.
Full story: https://gethealthbrief.com/story/health-prior-auth-denials-kff-2026

### BCBS Begins $2.6B Antitrust Settlement Payouts: Market & Regulatory Impact
2026-02-23 22:00:55 · Sentiment: Negative · Impact: 7/10 · Sources: 5

Blue Cross Blue Shield has commenced the distribution of a $2.67 billion settlement following a landmark antitrust class-action lawsuit. The payout marks the end of a decade-long legal battle over the association's non-compete rules and signals a structural shift in the health insurance landscape.
Full story: https://gethealthbrief.com/story/bcbs-antitrust-settlement-payouts-2-6-billion

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.